Formulations of a somatostatin modulator
US11266641B1 · kind B1 · utility
3Cited by
14References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2021 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Sep 7, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.